Justification MPT to SAT-Medrad Injector System.pdf
PDF 353 KB Posted
- Attached to
- 6515--Imaging Injector System
- Solicitation number
- 36C24624Q1066
About this file
This document is a Justification for a Single Source Award under Simplified Acquisition Procedures (SAP) for the procurement of a Medrad MRXperion Injector System, associated services, and accessories for the Department of Veterans Affairs (VA) Charles George VA Medical Center in Asheville, North Carolina.
The justification explains that the additional Medrad MRXperion Injector System is brand name specific and required for continuity of patient care, as it will be interoperable with the injector system currently in use at the facility. The estimated value of the proposed action is $127,585.89. Market research was conducted, and three small business authorized distributors were identified. The Contracting Officer has certified the justification in accordance with FAR 13.106-1(b).
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C24624Q1066.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
VHAPG Part 813.106 Simplified Acquisition Procedures: Soliciting from a Single Source Attachment 1: Single Source Justification for SAP under the SAT
Last Updated: 02/01/22 Page 1 of 1
DEPARTMENT OF VETERANS AFFAIRS
Justification for Single Source Awards IAW FAR 13.106-1 For
Over Micro-Purchase Threshold but Not Exceeding the SAT ($250K)
Acquisition Plan Action ID: 36C246-24-AP-4471
1. Contracting Activity: Department of Veterans Affairs, Network Contracting Office (NCO) 06, located at 100 Emancipation Drive, Hampton, VA 23667 in support of the Charles George VAMC located at 1100 Tunnel Road Asheville, North Carolina 28805; Purchase Request 637-24-3-996-0184.
2. Brief Description of Supplies/ Services required and the intended use/Estimated Amount: The Charles George VAMC has a requirement to procure an additional Medrad MRXperion Injector System, associated services and accessories. This unit is currently used at the facility to inject contrast into patients during various radiological procedures by CT, MRI, and IR units.
The estimated value of the proposed action is $ 127,585.89.
3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used: The additional Medrad MRXperion Injector is brand name specific as it will be interchangeable and interoperable with the currently utilized Injector which is needed for continuity of patient care.
4. Description of market research conducted and results or statement why it was not conducted:
Market research was conducted through multiple queries of VetCert, NAC, SAC, GSA, FPDS, Google, and market research for similar requirements. The OEM, Bayer Healthcare LLC. (LB) provided three
(3) Small Businesses authorized distributors: 1st American Medical Distribution, ASE Direct Inc., and QB Medical, Inc.
5. Contracting Officer's Certification: Purchase is approved in accordance with FAR13.106-1(b). I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.
Cherisse Hall Date Branch Chief https://www.acquisition.gov/?q=/browse/far/13 https://acquisition.gov/far/current/html/Subpart%2013_1.html#wp1125466
| 2024-07-08T07:45:24-0400 | |
| CHERISSE HALL |
File details come from the government source that posted it. Updated .